首页 | 本学科首页   官方微博 | 高级检索  
     


Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent,broad-spectrum enzymatic activity
Authors:Leslie W. Tari  Michael Trzoss  Daniel C. Bensen  Xiaoming Li  Zhiyong Chen  Thanh Lam  Junhu Zhang  Christopher J. Creighton  Mark L. Cunningham  Bryan Kwan  Mark Stidham  Karen J. Shaw  Felice C. Lightstone  Sergio E. Wong  Toan B. Nguyen  Jay Nix  John Finn
Affiliation:1. Trius Therapeutics, 6310 Nancy Ridge Dr., San Diego, CA 92121, USA;2. Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Livermore, CA 94550, USA;3. Advanced Light Source, Beamline 4.2.2, 1 Cyclotron Rd., Berkeley, CA 94720, USA
Abstract:The bacterial topoisomerases DNA gyrase (GyrB) and topoisomerase IV (ParE) are essential enzymes that control the topological state of DNA during replication. The high degree of conservation in the ATP-binding pockets of these enzymes make them appealing targets for broad-spectrum inhibitor development. A pyrrolopyrimidine scaffold was identified from a pharmacophore-based fragment screen with optimization potential. Structural characterization of inhibitor complexes conducted using selected GyrB/ParE orthologs aided in the identification of important steric, dynamic and compositional differences in the ATP-binding pockets of the targets, enabling the design of highly potent pyrrolopyrimidine inhibitors with broad enzymatic spectrum and dual targeting activity.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号